Cart
sales@molnova.com
Ditiocarb sodium
CAS No. 148-18-5
Ditiocarb sodium ( Sodium diethyldithiocarbamate )
Catalog No. M20541 CAS No. 148-18-5
Ditiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | 43 | In Stock |
|
Biological Information
-
Product NameDitiocarb sodium
-
NoteResearch use only not for human use.
-
Brief DescriptionDitiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
-
DescriptionDitiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
-
SynonymsSodium diethyldithiocarbamate
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number148-18-5
-
Formula Weight171.26
-
Molecular FormulaC5H10NNaS2
-
Purity>98% (HPLC)
-
SolubilityDMSO:300 mg/mL (1751.72 mM)
-
SMILES[Na+].CCN(CC)C([S-])=S
-
Chemical NameCarbamodithioic acid diethyl- sodium salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.El-Saharty A A El-Hammamy N H El-Araby H A . Sodium diethyldithiocarbamate as accelerator of the rate of copper cementation[J]. The Egyptian Journal of Aquatic Research 2015 41(4):289-293.
molnova catalog
related products
-
DPC-681
A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM.
-
Escin IA;Aescin IA
Escin IA is a triterpene saponin isolated from horse chestnut which inhibits HIV-1 protease with IC50 values of 35 μM. Escin IA has anti-TNBC metastasis activity and its action mechanisms involved inhibition of epithelial-mesenchymal transition process by down-regulating LOXL2 expression.
-
N.41
N.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).
